Literature DB >> 10025595

Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics.

M García-Carrasco1, R Cervera, J Rosas, M Ramos-Casals, R M Morlà, A Sisó, S Jiménez, L Pallarés, J Font, M Ingelmo.   

Abstract

The objective of the study was to determine the clinical and immunological characteristics of primary Sjogren's syndrome (SS) in patients with an older onset of the disease. We included 223 consecutive patients (204 female and 19 male; mean age at onset 53 years; range 15-87 years) visited in our Units. All patients were white and fulfilled four or more of the diagnostic criteria for SS proposed by the European Community Study Group in 1993. Disease onset was determined on the basis of the appearance of symptoms strongly suggestive of SS. In 31 patients the onset of disease occurred after the age of 70 years, and they represent the elderly-onset group described in this report. The remaining 192 patients presented disease onset before the age of 70 years, and they represent the younger-onset group. Of the 31 (14%) patients with elderly onset of primary SS, 26 were female and 5 male, and the disease onset occurred between 70 and 87 years (mean 74 years). The most common extraglandular manifestations were articular involvement (29%), hepatic involvement (20%), peripheral neuropathy (16%) and interstitial pneumopathy (13%). When compared with patients with a younger onset, the prevalences of glandular and extraglandular manifestations and immunological features (cryoglobulinemia, hypocomplementemia and positivity for RF, anti-Ro/SS-A or anti-La/SS-B) were similar in both groups. In conclusion, although primary SS is typically a disease of middle-aged adults, clinicians should note that it may be diagnosed frequently among elderly patients. However, we could not find any notable differences in clinical and immunological characteristics of patients with elderly onset of primary SS.

Entities:  

Mesh:

Year:  1999        PMID: 10025595     DOI: 10.1191/096120399678847353

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

Review 1.  Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.

Authors:  Ibtisam Al-Hashimi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 3.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

Review 4.  Oral manifestations of hepatitis C virus infection.

Authors:  Marco Carrozzo; Kara Scally
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 5.  Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Authors:  Kristine P Ng; David A Isenberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  The ocular surface immune system through the eyes of aging.

Authors:  Jeremias G Galletti; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2021-02-20       Impact factor: 5.033

Review 7.  Age-related changes in ocular mucosal tolerance: Lessons learned from gut and respiratory tract immunity.

Authors:  Jeremias G Galletti; Cintia S de Paiva
Journal:  Immunology       Date:  2021-05-02       Impact factor: 7.215

8.  [Primitive Sjögren syndrome in the elderly: clinical and immunological characteristics].

Authors:  Wafa Chebbi; Wafa Ben Salem; Rim Klii; Wassia Kessomtini; Saida Jerbi; Mohamed Habib Sfar
Journal:  Pan Afr Med J       Date:  2015-01-05

Review 9.  The epidemiology of Sjögren's syndrome.

Authors:  Ruchika Patel; Anupama Shahane
Journal:  Clin Epidemiol       Date:  2014-07-30       Impact factor: 4.790

Review 10.  Is primary Sjögren's syndrome a risk factor for malignancies different from lymphomas? What does the literature highlight about it?

Authors:  Ciro Manzo; Melek Kechida
Journal:  Reumatologia       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.